CurrentPremera BluecrossPolicy 7.01.162

Surgical Treatments for Lymphedema and Lipedema

Defines medical necessity and investigational status for surgical treatments (lipectomy/liposuction) for lipedema and various surgical interventions for lymphedema, documents required for review, and associated CPT coding. This is Part 1 of 2 of the policy.

Policy Summary

PayerPremera Bluecross

PolicySurgical Treatments for Lymphedema and Lipedema

Policy CodePolicy 7.01.162

Change TypeRevised and added criteriacoding update

Effective DateFeb 1, 2026

Next Review Date

Key ActionObtain and document prior authorization-level medical records: history/physical with requested procedure, evidence of functional impairment and >3 months conservative therapy, photographs, cuff phenomenon, BMI ≤35 kg/m², and plan for postoperative compression; ensure procedure is performed by a plastic surgeon.

SourceLink

POLICY UPDATE CHANGES

Policy replaces 7.01.162; effective date Feb. 1, 2026 with last revised Jan. 12, 2026.

Added medical necessity criteria (cuff phenomenon, BMI ≤35 kg/m², plastic surgeon requirement, staged liposuction allowance up to 12 months) on 12/01/24 effective March 5, 2025 after provider notification period.

Added CPT code 1019T (coding update) effective January 1, 2026.

Clarified BMI criterion wording to 'less than or equal to 35 kg/m²' during 02/01/26 interim review approved January 12, 2026.

1Medically Necessary Indication (lipedema liposuction)

Liposuction/LipectomyMedically necessary with criteria

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Investigational procedures (examples)

Coverage Summary

This policy (Part 1 of 2) defines medical necessity and investigational status for surgical treatments of lymphedema and lipedema, including lipectomy and liposuction for lipedema and a range of surgical interventions for lymphedema (e.g., physiologic microsurgeries, tissue transfers, and reductive techniques). Effective date: Feb. 1, 2026. Last review: Jan. 12, 2026. The policy replaces 7.01.162 and documents which procedures are considered medically necessary when specific criteria are met and which procedures remain investigational.

Key thresholds and quick facts

Prior conservative therapy duration>= 3 consecutive months

Staged liposuction aspirate volume threshold>= 5000 cc total aspirate during initial procedure

Staged procedures timingCompleted within a 12-month period to be considered medically necessary

BMI limit for eligibility<= 35 kg/m² (less than or equal to 35 kg/m²)

Medically Necessary Indication (count/label)1 — Medically Necessary Indication (lipedema liposuction)

Investigational procedures (label)Multiple — includes physiologic microsurgery, reverse lymphatic mapping, axillary mapping, liposuction/lipectomy for trunk/back, retreatment of previously treated areas

CPT codes listed (count/selection)10 — includes 1019T, 15832, 15833, 15836, 15839, 15877, 15878, 15879, 38999, 76499

Medical Necessity Criteria

Lipectomy or liposuction for treatment of lipedema - Medically Necessary

Covered when ALL of the following are met:

ALL of the following

There is documentation of significant physical functional impairment (e.g., difficulty ambulating or performing activities of daily living).
The individual has not responded to at least 3 consecutive months of optimal medical management (such as conservative treatment with compression garments and manual lymph drainage).
Conservative therapy should be documented in medical record.
The plan of care postoperatively is to continue to wear compression garments as instructed to maintain the benefits of treatment.
For the diagnosis of lipedema, all of the following clinical exam findings must be present:

Investigational / Not Medically Necessary

Lipectomy or liposuction - Not Medically Necessary / Investigational

Specific exclusions and investigational determinations:

ALL of the following

Liposuction or lipectomy for the treatment of lipedema in the trunk or back is considered investigational
Retreatment of a previously treated area using the same procedure is considered investigational

Surgical treatments for lymphedema - Investigational

The following surgical treatments to treat lymphedema are considered investigational:

ANY of the following

Lymphatic physiologic microsurgery (including lymphatico-lymphatic bypass, lymphovenous bypass, lymphaticovenular anastomosis, autologous lymph node transplantation, vascularized lymph node transfer)

Coding

Relevant CPT codes (listed in policy coding section)CPT

1019T	Lymphovenous bypass, including robotic assistance, when performed, per extremity (new code effective 01/01/26)
15832	Excision, excessive skin and subcutaneous tissue (includes lipectomy); thigh
15833	Excision, excessive skin and subcutaneous tissue (includes lipectomy); leg
15836	Excision, excessive skin and subcutaneous tissue (includes lipectomy); arm
15839	Excision, excessive skin and subcutaneous tissue (includes lipectomy); other area
15877	Suction assisted lipectomy; trunk
15878	Suction assisted lipectomy; upper extremity
15879	Suction assisted lipectomy; lower extremity
38999	Unlisted procedure, hemic or lymphatic system (may be used to report reverse lymphatic mapping)
76499	Unlisted diagnostic radiographic procedure

CPT codes historically added/updated in policy historyCPT

76499	Unlisted diagnostic radiographic procedure
15832	Excision; muscle fascia
15833	Lipectomy, trunk
15836	Liposuction, extensive areas
15839	Lipectomy, large area
15877	Liposuction, extremity
15878	Liposuction, other
15879	Liposuction, multiple areas
1019T	New CPT (listed in policy history) - code added January 1, 2026

Provider Actions / Documentation & Authorization

Documentation Required

Medical records must document medical necessity criteria

Medical records submitted for review must document that medical necessity criteria are met. Include office visit notes with the relevant history and physical that explicitly identify the specific surgical procedure requested, any physical functional impairment (for example, difficulty ambulating or performing activities of daily living), medical management tried and duration, the postoperative plan of care for continued use of compression garments, and submission of photographs of the affected extremities consistent with the diagnosis.

History and physical documenting the specific procedure requested
Documented functional impairment (e.g., ambulation, activities of daily living)
Documented medical management tried (at least 3 consecutive months when applicable) and response
Post-operative compression garment plan of care
Photographs of affected extremities consistent with diagnosis

Documentation Required

Specific exam findings required for lipedema requests

When the request is for treatment of lipedema, the clinical exam must explicitly document all required elements to support the diagnosis and medical necessity.

Background, Evidence, and Definitions

Lymphedema is swelling from accumulation of lymphatic fluid due to disrupted lymphatic drainage; it may be primary (congenital) or most often secondary to surgery, radiation, scarring, or other causes. Conservative management includes limb elevation, hygiene, compression therapy (garments, bandaging, pneumatic pumps), manual lymphatic drainage, and complete decongestive therapy. Physiologic microsurgical approaches (for example lymphaticovenular anastomosis, lymphovenous bypass, lymphatico-lymphatic bypass, and vascularized/autologous lymph node transfer) aim to reroute or restore lymphatic flow, while tissue-transfer and reductive/ablative techniques (direct excision and liposuction) remove fibrofatty tissue arising from chronic lymph stasis.

Lipedema is a chronic disorder characterized by disproportionate, often painful subcutaneous fat deposition in the extremities (typically bilateral, sparing the feet) that is frequently unresponsive to weight loss. Conservative care for lipedema includes manual lymphatic drainage, compression stockings, intermittent pneumatic compression, skin care, exercise, and diet when appropriate. Liposuction (including tumescent and specialized techniques such as power-, water-, laser-, ultrasound-, or radiofrequency-assisted) is being investigated as a treatment option for both lipedema and for lymphedema with substantial fibrofatty change.

Reductive procedures such as liposuction remove fibrous and fatty tissue via suction through cannulae and are intended for individuals with advanced disease who have not responded to conservative therapy; postoperative compression garments are required and may be needed indefinitely to maintain volume reduction and the benefits of treatment.

Evidence/Source	Summary
Lipedema liposuction evidence	Systematic reviews/meta-analyses of observational studies (latest meta-analysis of 9 studies, N=635) show improvements in quality of life and symptoms (pain, heaviness, bruising, walking difficulty) but are low-quality, geographically biased, durability uncertain, and RCTs are needed.
Physiologic microsurgery evidence	RCTs, observational studies, and systematic reviews exist (e.g., lymphaticovenular anastomosis, vascularized lymph node transfer) but evidence is insufficient to demonstrate definitive net health outcome improvement; more and larger RCTs needed.
ARM evidence in ALND	Pooled RCT evidence (systematic review of 5 RCTs) shows lower lymphedema risk with axillary reverse mapping in ALND (OR 0.20); oncologic safety not established (metastatic ARM nodes reported) and overall net health benefit remains insufficient.
NICE 2022 conclusion (chronic lymphedema)	NICE concluded evidence on liposuction for chronic lymphedema is adequate to support use provided clinical governance, consent, audit, and specialist centers/clinician expertise are in place.
NCCN	NCCN notes high-level evidence for lymphedema treatments is lacking and does not discuss physiologic microsurgical techniques.
ISL 2023 consensus	ISL 2023: liposuction can completely reduce non-pitting lymphedema due to fat deposition, but long-term management requires strict adherence to compression garments.
Policy investigational list (procedures)	Policy lists lymphatic physiologic microsurgery (LVB/LVA, autologous lymph node transfer/VLNT), tissue transfer (eg, omental flap), reductive/ablative techniques, reverse lymphatic mapping, and LYMPHA as investigational or with insufficient evidence in many contexts.
Policy lipedema liposuction criteria/history	Policy states liposuction/lipectomy for lipedema may be medically necessary when specific criteria are met (eg, ≥3 months conservative therapy, significant functional impairment, cuff phenomenon present, BMI ≤35 kg/m², plastic surgeon, postop compression plan); staged procedures may be considered for large aspirate (≈5000 cc) within 12 months.
Liposuction technique description	Tumescent and specialized liposuction techniques (power-assisted, water-assisted, laser/ultrasound/radiofrequency-assisted) described; postoperative compression garments may be required indefinitely to maintain volume reduction.

Definitions

Physical functional impairment (definition)

Medicare Determinations

No national coverage determination.

Revision History

2026-02-01replacement_effectiveLatest

Policy replaces 7.01.162; effective Feb. 1, 2026 (last revised Jan. 12, 2026).

2025-03-05added_investigational_criterion

Added investigational criterion: liposuction or lipectomy for trunk/back lipedema considered investigational; new medical necessity criteria (cuff phenomenon, BMI ≤35 kg/m², plastic surgeon requirement, staged liposuction allowance up to 12 months) added on 12/01/24 effective March 5, 2025 after provider notification period.

2026-01-01

Policy Summary

PayerPremera Bluecross

PolicySurgical Treatments for Lymphedema and Lipedema

Policy CodePolicy 7.01.162

Change TypeRevised and added criteriacoding update

Effective DateFeb 1, 2026

Next Review Date

SourceLink

On This Page

Bilateral symmetric adiposity in the extremities.

Tissue in affected areas is soft to palpation.

Tissue in affected areas is tender to palpation.

Evidence of cuff phenomenon (sparing of feet if lower extremities are affected, or sparing of hands if upper extremities are affected) is present.

BMI is less than or equal to 35 kg/m².<= 35 kg/m²

The requested surgical intervention will be performed by a plastic surgeon.

Submission of photographs documenting the affected extremities requested for treatment that are consistent with the diagnosis of lipedema.

Staged liposuction procedures

ALL of the following
- There is a large total volume of aspirate (i.e., greater than or equal to 5000 cc) during the initial procedure.>= 5000 cc
- Subsequent staged procedures are completed within a 12-month period.<= 12 months

Tissue transfer (e.g., omental or mesenteric flap)

Reductive/ablative techniques (investigational for lymphedema as listed)

Reverse lymphatic mapping - Investigational

Preventive procedures considered investigational:

Lymphatic physiologic microsurgery performed during nodal dissection or breast reconstruction to prevent lymphedema (including LYMPHA) in individuals treated for breast cancer is considered investigational

ref":"b2_2","title":"Preventive surgical treatment - Investigational"},{

citations([

Investigational / Not Medically Necessary

The policy historically and in updates considers certain procedures investigational:

ALL of the following

Lymphatic physiologic microsurgery to treat lymphedema in individuals who have been treated for breast cancer is investigational
Lymphatic physiologic microsurgery performed during nodal dissection or breast reconstruction to prevent lymphedema in individuals being treated for breast cancer is investigational
Lymphatic mapping (axillary mapping) considered investigational as of 05/01/19 (policy history entry)
Liposuction or lipectomy for the treatment of lipedema in the trunk or back is considered investigational (added 12/01/24)
Genitalia surgical treatment for lymphedema considered investigational (added 07/01/19)

Bilateral, symmetric adiposity of the extremities
Non-pitting edema
Tissue in affected areas soft to palpation (soft tissue turgor)
Tissue in affected areas tender to palpation
Evidence of cuff phenomenon (sparing of feet if lower extremities affected, or sparing of hands if upper extremities affected) — must be documented
Body mass index (BMI) documented and ≤ 35 kg/m²

Documentation Required

Provider specialty requirement

Ensure and document that the requested surgical intervention will be performed by a plastic surgeon. The medical record should explicitly state the performing provider's specialty (plastic surgery) and that the plastic surgeon will perform the procedure.

Billing Rule

Staged liposuction timing

Staged liposuction procedures for lipedema may be permitted when initial aspirate volume is large and when staged procedures are completed within a specified timeframe.

Staged procedures are allowable when the initial aspirate is ≥ 5000 cc
All staged procedures should be completed within 12 months of the initial procedure

Prior Authorization

Prior authorization implied by policy

Prior authorization should be obtained per the member's benefit plan as applicable. Benefits and prior authorization requirements vary by plan, so the provider should verify coverage and obtain authorization when required.

Obtain prior authorization per the member's plan when required
Benefits and PA requirements vary by contract — verify before scheduling

Limitation from normal physical functioning or baseline level of functioning (may include problems with ambulation, mobilization, communication, respiration, eating, swallowing, vision, facial expression, skin integrity, distortion of nearby body part(s) or obstruction of an orifice); excludes social, emotional and psychological impairments.

Cuff phenomenon (definition)Clinical finding of sparing of the distal extremity (feet or hands) when more proximal limb segments are affected; used as an inclusion criterion for liposuction/lipectomy medical necessity.

Added CPT code 1019T (Lymphovenous bypass, including robotic assistance, per extremity) effective January 1, 2026.

2026-01-12wording_clarification

Clarified BMI wording to 'less than or equal to 35 kg/m²' during 02/01/26 interim review approved January 12, 2026.